Hemostasis, the process by which the body stops bleeding, is a critical physiological function. In a laboratory setting, testing hemostasis is essential to understand how well the blood - clotting mechanism works, to diagnose bleeding disorders, and to evaluate the efficacy of hemostatic products.
Coagulation Screening Tests
One of the most common ways to test hemostasis in the laboratory is through coagulation screening tests. These tests give a general overview of the blood's ability to clot.
Prothrombin Time (PT)
The prothrombin time test measures the time it takes for the plasma to clot after the addition of tissue factor and calcium. It assesses the extrinsic and common pathways of the coagulation cascade. A prolonged PT may indicate a deficiency in factors II, V, VII, or X, or the presence of anticoagulants such as warfarin. The PT is reported in seconds and is often compared to a control value. The international normalized ratio (INR) is a standardized way of reporting PT results, which is especially useful when monitoring patients on anticoagulant therapy.
Activated Partial Thromboplastin Time (aPTT)
The aPTT test evaluates the intrinsic and common pathways of the coagulation system. It measures the time required for clot formation after the addition of an activator and calcium to the plasma. A prolonged aPTT can be due to deficiencies in factors VIII, IX, XI, or XII, or the presence of heparin or other anticoagulants. This test is crucial in the diagnosis of hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficiency).
Thrombin Time (TT)
The thrombin time measures the time it takes for fibrinogen to be converted to fibrin in the presence of thrombin. A prolonged TT can be caused by a low fibrinogen level, abnormal fibrinogen (dysfibrinogenemia), or the presence of fibrin degradation products or heparin.
Platelet Function Tests
Platelets play a vital role in hemostasis. They adhere to the damaged blood vessel wall, aggregate with each other, and release substances that promote clot formation.
Platelet Count
A simple but fundamental test is the platelet count. A normal platelet count ranges from 150,000 to 450,000 platelets per microliter of blood. A low platelet count (thrombocytopenia) can lead to increased bleeding risk, while a high platelet count (thrombocytosis) may increase the risk of thrombosis.
Platelet Aggregation Test
This test measures the ability of platelets to clump together in response to various agonists such as adenosine diphosphate (ADP), collagen, or epinephrine. Platelet - rich plasma is mixed with the agonist, and the change in light transmission is measured over time. A decrease in platelet aggregation can be seen in platelet function disorders, such as Glanzmann's thrombasthenia (a defect in platelet glycoprotein IIb/IIIa) or Bernard - Soulier syndrome (a defect in platelet glycoprotein Ib).
Bleeding Time
The bleeding time is a test that assesses the combined function of platelets and the blood vessel wall. A small incision is made on the forearm, and the time it takes for the bleeding to stop is measured. However, this test has limitations, as it is operator - dependent and is not very specific.
Fibrinolytic System Tests
The fibrinolytic system is responsible for breaking down blood clots after the damaged blood vessel has been repaired.
Fibrin Degradation Products (FDPs) and D - Dimer
FDPs are fragments produced when fibrin is broken down by plasmin. The D - dimer is a specific fibrin degradation product that is formed when cross - linked fibrin is degraded. Elevated levels of FDPs and D - Dimer can indicate increased fibrinolytic activity, which may be seen in conditions such as disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), or pulmonary embolism (PE).
Plasminogen Activity
Plasminogen is the precursor of plasmin, the enzyme responsible for fibrin degradation. Measuring plasminogen activity can help evaluate the function of the fibrinolytic system. A low plasminogen activity may be associated with an increased risk of thrombosis.
Testing Hemostatic Products in the Laboratory
As a hemostasis supplier, we are also interested in testing the efficacy of our hemostatic products. Our Absorbable Medical Gauze For Surgery, Biodegradable Styptic Powder, and Sterilized Hemostatic Gauze are designed to promote hemostasis in various surgical and medical settings.
In Vitro Tests
In vitro tests can be used to evaluate the basic properties of hemostatic products. For example, the ability of a hemostatic powder to absorb blood and promote clot formation can be tested by adding the powder to a sample of blood in a test tube and observing the time to clot formation. The absorbency of a hemostatic gauze can be measured by weighing the gauze before and after it has been in contact with a known volume of blood.
In Vivo Tests
In vivo tests are more complex but provide more relevant information about the performance of hemostatic products in a living organism. Animal models are often used to simulate surgical bleeding. For example, a liver injury model in rats can be used to test the efficacy of a hemostatic gauze. The time to hemostasis, the amount of blood loss, and the quality of the formed clot can be measured and compared between different products or treatment groups.
Conclusion
Laboratory testing of hemostasis is a multi - faceted process that involves a variety of tests to assess different aspects of the blood - clotting mechanism. From basic coagulation screening tests to specialized platelet function and fibrinolytic system tests, these evaluations are crucial for diagnosing bleeding and thrombotic disorders and for evaluating the effectiveness of hemostatic products.
If you are in the medical field and are interested in high - quality hemostatic products, we invite you to contact us for procurement and further discussions. Our team of experts is ready to provide you with detailed information about our products and how they can meet your specific needs.
References
- Hoffman M, Monroe DM 3rd. Hemostasis and thrombosis: basic principles and clinical practice. Lippincott Williams & Wilkins; 2018.
- George JN, Shattil SJ. The platelet: form and function. N Engl J Med. 2007;357(11):1014 - 1023.
- Levi M, van der Poll T. Hemostasis and thrombosis in infection and inflammation. J Thromb Haemost. 2017;15(1):36 - 47.